Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
COVID – Shielding Advice for Clinically Vunerable
Dept of Health & Social Care - ENGLAND : SHIELDING ADVICE FOR THE CLINICALLY EXTREMELY VULNERABLE TO STOP FROM APRIL. Advice to the clinically extremely vulnerable to shield ceases from Thursday 1 April, as virus infection rates continue to fall People on shielded...
PODCAST – Sally, Neuroendocrine Cancer Patient – Pain Control
📣 PODCAST - Rambles With Sally. In this episode Sally, Neuroendocrine Cancer patient, talks to us about pain control. Thank you Sally for taking the time to record this podcast and for sharing your advice and experience. You can listen to Sally's podcast here ➡️...
Neuroendocrine Cancer community took part in Cancer 52 COVID-19 patient survey
The Neuroendocrine Cancer community were invited to and took part in Cancer 52 second patient survey looking at the impact of the Covid-19 pandemic on people with rare and less common cancers ran from early December 2020 to mid-January 2021. Over 500 people, with a...



